高性能PBPK模型用于预测CYP3A4诱导介导的药物相互作用:一种精细和验证的方法
Cheng-Guang Yang1, Tao Chen2, Wen-Teng Si3
1Department of General Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in pharmacology
|March 13, 2025
概括
一个新的生理学基础的药理动力学 (PBPK) 模型准确地预测了由细胞染色体P450酶3A4 (CYP3A4) 诱导引起的药物相互作用 (DDI). 该工具通过可靠预测DDI风险,增强早期药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 临床药理学 临床药理学
背景情况:
- 细胞染色体P450酶3A4 (CYP3A4) 通过代谢诱导显著影响药物相互作用 (DDI).
- 通过CYP3A4介导的DDI可以导致药物的疗效降低或毒性增加,这在临床开发中构成了挑战.
研究的目的:
- 开发和验证一种生理学基础的药理动力学 (PBPK) 模型,用于预测CYP3A4诱导介导的DDI.
- 在临床药物开发的早期阶段评估模型的预测性能.
主要方法:
- 开发并验证了一种PBPK模型,用于使用人类的药理动力学数据,用于已知的CYP3A4诱导剂利芬素.
- 为"受害者"药物构建并验证的PBPK模型.
- 评估了PBPK-DDI模型对曲线下的面积 (AUC) 和最大度 (Cmax) 的预测准确性,并使用既定的标准与实证数据对比.
主要成果:
- 里芬素PBPK模型准确地模拟了人类的药理动力学特征.
- PBPK-DDI模型实现了AUC比率 (89%在0.5-2倍内,79%满足客户标准) 和Cmax比率 (93%在可接受范围内) 的高预测准确度.
- 与静态模型相比,PBPK-DDI模型在预测CYP3A4诱导DDI方面表现优越.
结论:
- 开发的PBPK-DDI模型是预测CYP3A4诱导介导的DDI的可靠工具.
- 该模型的高预测准确性支持其在药物开发和临床药理学中的实用性.
- 未来的改进有可能进一步增强模型的预测能力.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
23
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
23
Physiological Pharmacokinetic Models: Assumption with Protein Binding
29
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
29
Pharmacokinetic Models: Comparison and Selection Criterion
35
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
35
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
67
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
67
Pharmacokinetic Models: Overview
538
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
538
Model Approaches for Pharmacokinetic Data: Physiological Models
26
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
26


